Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Citrus pectin, particularly in its modified form (Modified Citrus Pectin, or MCP), has received some scientific attention regarding its potential effects on the lymphatic system, especially in the context of detoxification and immune support. MCP is a complex polysaccharide derived from the peel and pulp of citrus fruits and is more readily absorbed by the body compared to regular citrus pectin.

Several in vitro and animal studies suggest that MCP can bind to galectin-3, a protein implicated in inflammation, fibrosis, and cancer metastasis, which are processes involving the lymphatic system. By binding galectin-3, MCP may help inhibit tumor cell aggregation and metastasis, processes that often spread through the lymphatics. Some small clinical trials and case reports in humans have explored MCP for cancer support, but these are preliminary and typically focus on anti-metastatic or detoxification properties rather than direct lymphatic drainage or health.

Overall, while the use of citrus pectin for lymphatic support has some basis in early scientific research—mainly via anti-metastatic and detoxification mechanisms related to galectin-3 inhibition—robust human clinical data is lacking. Therefore, the evidence is rated low (2/5), and more high-quality studies are needed to establish clear benefits for the lymphatic system.

More about citrus pectin
More about Lymphatics

Other ingredients that support Lymphatics

Other body systems supported by citrus pectin

Products containing citrus pectin